Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


Trump says Iran war deal close as Strait of Hormuz tensions linger
Ukraine and Russia trade overnight drone strikes, officials say
UN says Taliban arrest 30 women for violating hijab rules in Afghanistan
Trump cancels US strikes on Iran, citing progress in talks
South Korea court sentences ex-President Yoon to 30-year jail term in drone case
Thai king's eldest daughter dies, aged 47, after long illness
US confirms third strike on Indian-crewed tankers this week
UK defence minister Healey quits, says PM Starmer's plans fail to keep country safe
